BRIEF-Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting
Reuters
Jan 06
BRIEF-Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting
Jan 6 (Reuters) - Ernexa Therapeutics Inc ERNA.O:
ERNEXA THERAPEUTICS ANNOUNCES SUCCESSFUL PRE-IND FDA MEETING AND CONTINUES PROGRESS TOWARD FIRST-IN-HUMAN TRIAL IN OVARIAN CANCER
ERNEXA THERAPEUTICS INC - ON TRACK TO INITIATE FIH TRIAL FOR OVARIAN CANCER IN 2026
Source text: ID:nGNX1j4X05
Further company coverage: ERNA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.